GlassScriptPhysician profile
Mikel Sadek
NPI 1063672764
$113,130.95
in general payments reported to CMS, 2019-2025
23 companies · $35K in 2025
The $35K reported for 2025 was more than what 98% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11K · 2020: $9,221 · 2021: $7,596 · 2022: $14K · 2023: $18K · 2024: $20K · 2025: $35K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $52K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $7,600 · Food and Beverage: $4,763 · Honoraria: $3,796 · Travel and Lodging: $3,533.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $52,190.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $7,600.00 |
| Food and Beverage | $4,762.66 |
| Honoraria | $3,796.00 |
| Travel and Lodging | $3,532.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $92,401.01 | 2019-2025 | General - Therapies, Jetstream Sc, Eluvia |
| Bard Peripheral Vascular, INC. | $11,779.43 | 2022-2025 | Rotarexs 6 F X 135 Cm |
| Argon Medical Devices, INC. | $4,366.99 | 2024-2025 | Clot Management, Clot Mgmt |
| Cook Incorporated | $1,240.00 | 2024 | Zilver Vena |
| Inari Medical, INC. | $942.99 | 2019-2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| W. L. Gore & Associates, INC. | $566.59 | 2019-2025 | Gore Viabahn Vbx Balloon Expandable Endo |
| Baxter Healthcare | $528.04 | 2022-2025 | Floseal, Preveleak, Perclot |
| Cook Medical LLC | $233.96 | 2019-2025 | Zenith Alpha, Zenith Spiral-Z |
| Humacyte Global, INC. | $217.82 | 2025 | |
| Cardiovascular Systems INC. | $154.47 | 2021-2023 | |
| Janssen Pharmaceuticals, INC | $151.54 | 2021-2024 | Xarelto |
| Endologix LLC | $112.61 | 2019 | |
| Abbott Laboratories | $69.36 | 2023-2025 | Diamondback Peripheral, Esprit |
| Medtronic, INC. | $62.69 | 2024-2025 | Endurant Iis, Venaseal |
| Silk Road Medical, INC. | $61.84 | 2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $55.00 | 2022-2025 | |
| Penumbra, INC. | $52.53 | 2023-2025 | Penumbra System, Indigo System |
| Terumo Medical Corporation | $41.79 | 2024 | Azur Cx Detachable, Navicross |
| Angiodynamics, INC. | $41.22 | 2023 | Alphavac |
| E.R. Squibb & Sons, L.L.C. | $37.69 | 2022-2025 | Camzyos |
| Becton, Dickinson and Company | $13.38 | 2024 | Venovo |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mikel Sadek listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
The CSV has this whole record: totals, yearly figures, every listed company, payment types, and product associations.
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.